IONS: Ionis Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 5,441.14
Enterprise Value ($M) 4,959.14
Book Value ($M) 662.00
Book Value / Share 4.19
Price / Book 8.22
NCAV ($M) 295.00
NCAV / Share 1.87
Price / NCAV 18.44

Profitability (mra)
Return on Invested Capital (ROIC) -0.13
Return on Assets (ROA) -0.12
Return on Equity (ROE) -0.93

Liquidity (mrq)
Quick Ratio 8.83
Current Ratio 8.93

Balance Sheet (mrq) ($M)
Current Assets 2,714.00
Assets 3,081.00
Liabilities 2,419.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
01-08 SCHEDULE 13G/A Vanguard Group Inc
11-14 13G/A Bb Biotech Ag 5.00 -8.61
11-14 13G/A T. Rowe Price Investment Management, Inc. 9.00 7.32
11-08 13G Wellington Management Group Llp 5.76 34.37
02-09 13G/A Fmr Llc 15.00 1.00
01-26 13G/A BlackRock, Inc. 6.30 -1.37

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q
2024-02-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-24 252,554 1,206,482 20.93
2025-01-23 611,673 2,055,805 29.75
2025-01-22 116,582 636,127 18.33
2025-01-21 227,173 1,185,293 19.17

(click for more detail)

Similar Companies
INVA – Innoviva, Inc. INZY – Inozyme Pharma, Inc.
IOBT – IO Biotech, Inc. IPSC – Century Therapeutics, Inc.
IRWD – Ironwood Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io